Global Recombinant Antibody Production Service Supply, Demand and Key Producers, 2023-2029

Page: 115

Published Date: 26 Jul 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Recombinant Antibody Production Service market size is expected to reach $ 1207.1 million by 2029, rising at a market growth of 5.4% CAGR during the forecast period (2023-2029).

This report studies the global Recombinant Antibody Production Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Antibody Production Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Antibody Production Service that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Antibody Production Service total market, 2018-2029, (USD Million)
Global Recombinant Antibody Production Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Recombinant Antibody Production Service total market, key domestic companies and share, (USD Million)
Global Recombinant Antibody Production Service revenue by player and market share 2018-2023, (USD Million)
Global Recombinant Antibody Production Service total market by Type, CAGR, 2018-2029, (USD Million)
Global Recombinant Antibody Production Service total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Recombinant Antibody Production Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include evitria SA, Bon Opus Biosciences, Biomatik, Biointron Biological Inc., Sino Biological, ProSci Inc, GenScript, RayBiotech and Cygnus Technologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Antibody Production Service market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Antibody Production Service Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Recombinant Antibody Production Service Market, Segmentation by Type
    High-throughput Antibody Production Service
    Small to Mid-scale Antibody Production Service
    Large-scale Antibody Production Service
    Chimeric Antibody Production Service
    Antibody Fragment Production Service
    Bispecific Antibody Production Service
    Others

Global Recombinant Antibody Production Service Market, Segmentation by Application
    Pharmaceutical
    Biotechnology Company
    Others

Companies Profiled:
    evitria SA
    Bon Opus Biosciences
    Biomatik
    Biointron Biological Inc.
    Sino Biological
    ProSci Inc
    GenScript
    RayBiotech
    Cygnus Technologies
    Cusabio Technology
    Absolute Antibody
    Cayman Chemical
    Creative Biolabs
    Promab Biotechnologies
    Leinco Technologies
    R&D Systems
    Rapid Novor
    ACROBiosystems

Key Questions Answered
1. How big is the global Recombinant Antibody Production Service market?
2. What is the demand of the global Recombinant Antibody Production Service market?
3. What is the year over year growth of the global Recombinant Antibody Production Service market?
4. What is the total value of the global Recombinant Antibody Production Service market?
5. Who are the major players in the global Recombinant Antibody Production Service market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Recombinant Antibody Production Service Introduction
    1.2 World Recombinant Antibody Production Service Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Recombinant Antibody Production Service Total Market by Region (by Headquarter Location)
        1.3.1 World Recombinant Antibody Production Service Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Recombinant Antibody Production Service Market Size (2018-2029)
        1.3.3 China Recombinant Antibody Production Service Market Size (2018-2029)
        1.3.4 Europe Recombinant Antibody Production Service Market Size (2018-2029)
        1.3.5 Japan Recombinant Antibody Production Service Market Size (2018-2029)
        1.3.6 South Korea Recombinant Antibody Production Service Market Size (2018-2029)
        1.3.7 ASEAN Recombinant Antibody Production Service Market Size (2018-2029)
        1.3.8 India Recombinant Antibody Production Service Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Recombinant Antibody Production Service Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Recombinant Antibody Production Service Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Recombinant Antibody Production Service Consumption Value (2018-2029)
    2.2 World Recombinant Antibody Production Service Consumption Value by Region
        2.2.1 World Recombinant Antibody Production Service Consumption Value by Region (2018-2023)
        2.2.2 World Recombinant Antibody Production Service Consumption Value Forecast by Region (2024-2029)
    2.3 United States Recombinant Antibody Production Service Consumption Value (2018-2029)
    2.4 China Recombinant Antibody Production Service Consumption Value (2018-2029)
    2.5 Europe Recombinant Antibody Production Service Consumption Value (2018-2029)
    2.6 Japan Recombinant Antibody Production Service Consumption Value (2018-2029)
    2.7 South Korea Recombinant Antibody Production Service Consumption Value (2018-2029)
    2.8 ASEAN Recombinant Antibody Production Service Consumption Value (2018-2029)
    2.9 India Recombinant Antibody Production Service Consumption Value (2018-2029)

3 World Recombinant Antibody Production Service Companies Competitive Analysis
    3.1 World Recombinant Antibody Production Service Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Recombinant Antibody Production Service Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Recombinant Antibody Production Service in 2022
        3.2.3 Global Concentration Ratios (CR8) for Recombinant Antibody Production Service in 2022
    3.3 Recombinant Antibody Production Service Company Evaluation Quadrant
    3.4 Recombinant Antibody Production Service Market: Overall Company Footprint Analysis
        3.4.1 Recombinant Antibody Production Service Market: Region Footprint
        3.4.2 Recombinant Antibody Production Service Market: Company Product Type Footprint
        3.4.3 Recombinant Antibody Production Service Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Recombinant Antibody Production Service Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Recombinant Antibody Production Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Recombinant Antibody Production Service Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Recombinant Antibody Production Service Consumption Value Comparison
        4.2.1 United States VS China: Recombinant Antibody Production Service Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Recombinant Antibody Production Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Recombinant Antibody Production Service Companies and Market Share, 2018-2023
        4.3.1 United States Based Recombinant Antibody Production Service Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Recombinant Antibody Production Service Revenue, (2018-2023)
    4.4 China Based Companies Recombinant Antibody Production Service Revenue and Market Share, 2018-2023
        4.4.1 China Based Recombinant Antibody Production Service Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Recombinant Antibody Production Service Revenue, (2018-2023)
    4.5 Rest of World Based Recombinant Antibody Production Service Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Recombinant Antibody Production Service Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Recombinant Antibody Production Service Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Recombinant Antibody Production Service Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 High-throughput Antibody Production Service
        5.2.2 Small to Mid-scale Antibody Production Service
        5.2.3 Large-scale Antibody Production Service
        5.2.4 Chimeric Antibody Production Service
        5.2.5 Antibody Fragment Production Service
        5.2.6 Bispecific Antibody Production Service
        5.2.7 Others
    5.3 Market Segment by Type
        5.3.1 World Recombinant Antibody Production Service Market Size by Type (2018-2023)
        5.3.2 World Recombinant Antibody Production Service Market Size by Type (2024-2029)
        5.3.3 World Recombinant Antibody Production Service Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Recombinant Antibody Production Service Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical
        6.2.2 Biotechnology Company
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Recombinant Antibody Production Service Market Size by Application (2018-2023)
        6.3.2 World Recombinant Antibody Production Service Market Size by Application (2024-2029)
        6.3.3 World Recombinant Antibody Production Service Market Size by Application (2018-2029)

7 Company Profiles
    7.1 evitria SA
        7.1.1 evitria SA Details
        7.1.2 evitria SA Major Business
        7.1.3 evitria SA Recombinant Antibody Production Service Product and Services
        7.1.4 evitria SA Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 evitria SA Recent Developments/Updates
        7.1.6 evitria SA Competitive Strengths & Weaknesses
    7.2 Bon Opus Biosciences
        7.2.1 Bon Opus Biosciences Details
        7.2.2 Bon Opus Biosciences Major Business
        7.2.3 Bon Opus Biosciences Recombinant Antibody Production Service Product and Services
        7.2.4 Bon Opus Biosciences Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Bon Opus Biosciences Recent Developments/Updates
        7.2.6 Bon Opus Biosciences Competitive Strengths & Weaknesses
    7.3 Biomatik
        7.3.1 Biomatik Details
        7.3.2 Biomatik Major Business
        7.3.3 Biomatik Recombinant Antibody Production Service Product and Services
        7.3.4 Biomatik Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Biomatik Recent Developments/Updates
        7.3.6 Biomatik Competitive Strengths & Weaknesses
    7.4 Biointron Biological Inc.
        7.4.1 Biointron Biological Inc. Details
        7.4.2 Biointron Biological Inc. Major Business
        7.4.3 Biointron Biological Inc. Recombinant Antibody Production Service Product and Services
        7.4.4 Biointron Biological Inc. Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Biointron Biological Inc. Recent Developments/Updates
        7.4.6 Biointron Biological Inc. Competitive Strengths & Weaknesses
    7.5 Sino Biological
        7.5.1 Sino Biological Details
        7.5.2 Sino Biological Major Business
        7.5.3 Sino Biological Recombinant Antibody Production Service Product and Services
        7.5.4 Sino Biological Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Sino Biological Recent Developments/Updates
        7.5.6 Sino Biological Competitive Strengths & Weaknesses
    7.6 ProSci Inc
        7.6.1 ProSci Inc Details
        7.6.2 ProSci Inc Major Business
        7.6.3 ProSci Inc Recombinant Antibody Production Service Product and Services
        7.6.4 ProSci Inc Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 ProSci Inc Recent Developments/Updates
        7.6.6 ProSci Inc Competitive Strengths & Weaknesses
    7.7 GenScript
        7.7.1 GenScript Details
        7.7.2 GenScript Major Business
        7.7.3 GenScript Recombinant Antibody Production Service Product and Services
        7.7.4 GenScript Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 GenScript Recent Developments/Updates
        7.7.6 GenScript Competitive Strengths & Weaknesses
    7.8 RayBiotech
        7.8.1 RayBiotech Details
        7.8.2 RayBiotech Major Business
        7.8.3 RayBiotech Recombinant Antibody Production Service Product and Services
        7.8.4 RayBiotech Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 RayBiotech Recent Developments/Updates
        7.8.6 RayBiotech Competitive Strengths & Weaknesses
    7.9 Cygnus Technologies
        7.9.1 Cygnus Technologies Details
        7.9.2 Cygnus Technologies Major Business
        7.9.3 Cygnus Technologies Recombinant Antibody Production Service Product and Services
        7.9.4 Cygnus Technologies Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Cygnus Technologies Recent Developments/Updates
        7.9.6 Cygnus Technologies Competitive Strengths & Weaknesses
    7.10 Cusabio Technology
        7.10.1 Cusabio Technology Details
        7.10.2 Cusabio Technology Major Business
        7.10.3 Cusabio Technology Recombinant Antibody Production Service Product and Services
        7.10.4 Cusabio Technology Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Cusabio Technology Recent Developments/Updates
        7.10.6 Cusabio Technology Competitive Strengths & Weaknesses
    7.11 Absolute Antibody
        7.11.1 Absolute Antibody Details
        7.11.2 Absolute Antibody Major Business
        7.11.3 Absolute Antibody Recombinant Antibody Production Service Product and Services
        7.11.4 Absolute Antibody Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Absolute Antibody Recent Developments/Updates
        7.11.6 Absolute Antibody Competitive Strengths & Weaknesses
    7.12 Cayman Chemical
        7.12.1 Cayman Chemical Details
        7.12.2 Cayman Chemical Major Business
        7.12.3 Cayman Chemical Recombinant Antibody Production Service Product and Services
        7.12.4 Cayman Chemical Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Cayman Chemical Recent Developments/Updates
        7.12.6 Cayman Chemical Competitive Strengths & Weaknesses
    7.13 Creative Biolabs
        7.13.1 Creative Biolabs Details
        7.13.2 Creative Biolabs Major Business
        7.13.3 Creative Biolabs Recombinant Antibody Production Service Product and Services
        7.13.4 Creative Biolabs Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Creative Biolabs Recent Developments/Updates
        7.13.6 Creative Biolabs Competitive Strengths & Weaknesses
    7.14 Promab Biotechnologies
        7.14.1 Promab Biotechnologies Details
        7.14.2 Promab Biotechnologies Major Business
        7.14.3 Promab Biotechnologies Recombinant Antibody Production Service Product and Services
        7.14.4 Promab Biotechnologies Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Promab Biotechnologies Recent Developments/Updates
        7.14.6 Promab Biotechnologies Competitive Strengths & Weaknesses
    7.15 Leinco Technologies
        7.15.1 Leinco Technologies Details
        7.15.2 Leinco Technologies Major Business
        7.15.3 Leinco Technologies Recombinant Antibody Production Service Product and Services
        7.15.4 Leinco Technologies Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Leinco Technologies Recent Developments/Updates
        7.15.6 Leinco Technologies Competitive Strengths & Weaknesses
    7.16 R&D Systems
        7.16.1 R&D Systems Details
        7.16.2 R&D Systems Major Business
        7.16.3 R&D Systems Recombinant Antibody Production Service Product and Services
        7.16.4 R&D Systems Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 R&D Systems Recent Developments/Updates
        7.16.6 R&D Systems Competitive Strengths & Weaknesses
    7.17 Rapid Novor
        7.17.1 Rapid Novor Details
        7.17.2 Rapid Novor Major Business
        7.17.3 Rapid Novor Recombinant Antibody Production Service Product and Services
        7.17.4 Rapid Novor Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Rapid Novor Recent Developments/Updates
        7.17.6 Rapid Novor Competitive Strengths & Weaknesses
    7.18 ACROBiosystems
        7.18.1 ACROBiosystems Details
        7.18.2 ACROBiosystems Major Business
        7.18.3 ACROBiosystems Recombinant Antibody Production Service Product and Services
        7.18.4 ACROBiosystems Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 ACROBiosystems Recent Developments/Updates
        7.18.6 ACROBiosystems Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Recombinant Antibody Production Service Industry Chain
    8.2 Recombinant Antibody Production Service Upstream Analysis
    8.3 Recombinant Antibody Production Service Midstream Analysis
    8.4 Recombinant Antibody Production Service Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Recombinant Antibody Production Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Recombinant Antibody Production Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Recombinant Antibody Production Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Recombinant Antibody Production Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Recombinant Antibody Production Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Recombinant Antibody Production Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Recombinant Antibody Production Service Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Recombinant Antibody Production Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Recombinant Antibody Production Service Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Recombinant Antibody Production Service Players in 2022
    Table 12. World Recombinant Antibody Production Service Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Recombinant Antibody Production Service Company Evaluation Quadrant
    Table 14. Head Office of Key Recombinant Antibody Production Service Player
    Table 15. Recombinant Antibody Production Service Market: Company Product Type Footprint
    Table 16. Recombinant Antibody Production Service Market: Company Product Application Footprint
    Table 17. Recombinant Antibody Production Service Mergers & Acquisitions Activity
    Table 18. United States VS China Recombinant Antibody Production Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Recombinant Antibody Production Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Recombinant Antibody Production Service Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Recombinant Antibody Production Service Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Recombinant Antibody Production Service Revenue Market Share (2018-2023)
    Table 23. China Based Recombinant Antibody Production Service Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Recombinant Antibody Production Service Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Recombinant Antibody Production Service Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Recombinant Antibody Production Service Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Recombinant Antibody Production Service Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Recombinant Antibody Production Service Revenue Market Share (2018-2023)
    Table 29. World Recombinant Antibody Production Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Recombinant Antibody Production Service Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Recombinant Antibody Production Service Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Recombinant Antibody Production Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Recombinant Antibody Production Service Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Recombinant Antibody Production Service Market Size by Application (2024-2029) & (USD Million)
    Table 35. evitria SA Basic Information, Area Served and Competitors
    Table 36. evitria SA Major Business
    Table 37. evitria SA Recombinant Antibody Production Service Product and Services
    Table 38. evitria SA Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. evitria SA Recent Developments/Updates
    Table 40. evitria SA Competitive Strengths & Weaknesses
    Table 41. Bon Opus Biosciences Basic Information, Area Served and Competitors
    Table 42. Bon Opus Biosciences Major Business
    Table 43. Bon Opus Biosciences Recombinant Antibody Production Service Product and Services
    Table 44. Bon Opus Biosciences Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Bon Opus Biosciences Recent Developments/Updates
    Table 46. Bon Opus Biosciences Competitive Strengths & Weaknesses
    Table 47. Biomatik Basic Information, Area Served and Competitors
    Table 48. Biomatik Major Business
    Table 49. Biomatik Recombinant Antibody Production Service Product and Services
    Table 50. Biomatik Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Biomatik Recent Developments/Updates
    Table 52. Biomatik Competitive Strengths & Weaknesses
    Table 53. Biointron Biological Inc. Basic Information, Area Served and Competitors
    Table 54. Biointron Biological Inc. Major Business
    Table 55. Biointron Biological Inc. Recombinant Antibody Production Service Product and Services
    Table 56. Biointron Biological Inc. Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Biointron Biological Inc. Recent Developments/Updates
    Table 58. Biointron Biological Inc. Competitive Strengths & Weaknesses
    Table 59. Sino Biological Basic Information, Area Served and Competitors
    Table 60. Sino Biological Major Business
    Table 61. Sino Biological Recombinant Antibody Production Service Product and Services
    Table 62. Sino Biological Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Sino Biological Recent Developments/Updates
    Table 64. Sino Biological Competitive Strengths & Weaknesses
    Table 65. ProSci Inc Basic Information, Area Served and Competitors
    Table 66. ProSci Inc Major Business
    Table 67. ProSci Inc Recombinant Antibody Production Service Product and Services
    Table 68. ProSci Inc Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. ProSci Inc Recent Developments/Updates
    Table 70. ProSci Inc Competitive Strengths & Weaknesses
    Table 71. GenScript Basic Information, Area Served and Competitors
    Table 72. GenScript Major Business
    Table 73. GenScript Recombinant Antibody Production Service Product and Services
    Table 74. GenScript Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. GenScript Recent Developments/Updates
    Table 76. GenScript Competitive Strengths & Weaknesses
    Table 77. RayBiotech Basic Information, Area Served and Competitors
    Table 78. RayBiotech Major Business
    Table 79. RayBiotech Recombinant Antibody Production Service Product and Services
    Table 80. RayBiotech Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. RayBiotech Recent Developments/Updates
    Table 82. RayBiotech Competitive Strengths & Weaknesses
    Table 83. Cygnus Technologies Basic Information, Area Served and Competitors
    Table 84. Cygnus Technologies Major Business
    Table 85. Cygnus Technologies Recombinant Antibody Production Service Product and Services
    Table 86. Cygnus Technologies Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Cygnus Technologies Recent Developments/Updates
    Table 88. Cygnus Technologies Competitive Strengths & Weaknesses
    Table 89. Cusabio Technology Basic Information, Area Served and Competitors
    Table 90. Cusabio Technology Major Business
    Table 91. Cusabio Technology Recombinant Antibody Production Service Product and Services
    Table 92. Cusabio Technology Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Cusabio Technology Recent Developments/Updates
    Table 94. Cusabio Technology Competitive Strengths & Weaknesses
    Table 95. Absolute Antibody Basic Information, Area Served and Competitors
    Table 96. Absolute Antibody Major Business
    Table 97. Absolute Antibody Recombinant Antibody Production Service Product and Services
    Table 98. Absolute Antibody Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Absolute Antibody Recent Developments/Updates
    Table 100. Absolute Antibody Competitive Strengths & Weaknesses
    Table 101. Cayman Chemical Basic Information, Area Served and Competitors
    Table 102. Cayman Chemical Major Business
    Table 103. Cayman Chemical Recombinant Antibody Production Service Product and Services
    Table 104. Cayman Chemical Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Cayman Chemical Recent Developments/Updates
    Table 106. Cayman Chemical Competitive Strengths & Weaknesses
    Table 107. Creative Biolabs Basic Information, Area Served and Competitors
    Table 108. Creative Biolabs Major Business
    Table 109. Creative Biolabs Recombinant Antibody Production Service Product and Services
    Table 110. Creative Biolabs Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Creative Biolabs Recent Developments/Updates
    Table 112. Creative Biolabs Competitive Strengths & Weaknesses
    Table 113. Promab Biotechnologies Basic Information, Area Served and Competitors
    Table 114. Promab Biotechnologies Major Business
    Table 115. Promab Biotechnologies Recombinant Antibody Production Service Product and Services
    Table 116. Promab Biotechnologies Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Promab Biotechnologies Recent Developments/Updates
    Table 118. Promab Biotechnologies Competitive Strengths & Weaknesses
    Table 119. Leinco Technologies Basic Information, Area Served and Competitors
    Table 120. Leinco Technologies Major Business
    Table 121. Leinco Technologies Recombinant Antibody Production Service Product and Services
    Table 122. Leinco Technologies Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Leinco Technologies Recent Developments/Updates
    Table 124. Leinco Technologies Competitive Strengths & Weaknesses
    Table 125. R&D Systems Basic Information, Area Served and Competitors
    Table 126. R&D Systems Major Business
    Table 127. R&D Systems Recombinant Antibody Production Service Product and Services
    Table 128. R&D Systems Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. R&D Systems Recent Developments/Updates
    Table 130. R&D Systems Competitive Strengths & Weaknesses
    Table 131. Rapid Novor Basic Information, Area Served and Competitors
    Table 132. Rapid Novor Major Business
    Table 133. Rapid Novor Recombinant Antibody Production Service Product and Services
    Table 134. Rapid Novor Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Rapid Novor Recent Developments/Updates
    Table 136. ACROBiosystems Basic Information, Area Served and Competitors
    Table 137. ACROBiosystems Major Business
    Table 138. ACROBiosystems Recombinant Antibody Production Service Product and Services
    Table 139. ACROBiosystems Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 140. Global Key Players of Recombinant Antibody Production Service Upstream (Raw Materials)
    Table 141. Recombinant Antibody Production Service Typical Customers
List of Figure
    Figure 1. Recombinant Antibody Production Service Picture
    Figure 2. World Recombinant Antibody Production Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Recombinant Antibody Production Service Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Recombinant Antibody Production Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Recombinant Antibody Production Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Recombinant Antibody Production Service Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Recombinant Antibody Production Service Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Recombinant Antibody Production Service Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Recombinant Antibody Production Service Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Recombinant Antibody Production Service Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Recombinant Antibody Production Service Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Recombinant Antibody Production Service Revenue (2018-2029) & (USD Million)
    Figure 13. Recombinant Antibody Production Service Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Recombinant Antibody Production Service Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Recombinant Antibody Production Service Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Recombinant Antibody Production Service Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Recombinant Antibody Production Service Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Recombinant Antibody Production Service Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Recombinant Antibody Production Service Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Recombinant Antibody Production Service Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Recombinant Antibody Production Service Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Recombinant Antibody Production Service Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Recombinant Antibody Production Service by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Recombinant Antibody Production Service Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Recombinant Antibody Production Service Markets in 2022
    Figure 27. United States VS China: Recombinant Antibody Production Service Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Recombinant Antibody Production Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Recombinant Antibody Production Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Recombinant Antibody Production Service Market Size Market Share by Type in 2022
    Figure 31. High-throughput Antibody Production Service
    Figure 32. Small to Mid-scale Antibody Production Service
    Figure 33. Large-scale Antibody Production Service
    Figure 34. Chimeric Antibody Production Service
    Figure 35. Antibody Fragment Production Service
    Figure 36. Bispecific Antibody Production Service
    Figure 37. Others
    Figure 38. World Recombinant Antibody Production Service Market Size Market Share by Type (2018-2029)
    Figure 39. World Recombinant Antibody Production Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Recombinant Antibody Production Service Market Size Market Share by Application in 2022
    Figure 41. Pharmaceutical
    Figure 42. Biotechnology Company
    Figure 43. Others
    Figure 44. Recombinant Antibody Production Service Industrial Chain
    Figure 45. Methodology
    Figure 46. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

evitria SA
Bon Opus Biosciences
Biomatik
Biointron Biological Inc.
Sino Biological
ProSci Inc
GenScript
RayBiotech
Cygnus Technologies
Cusabio Technology
Absolute Antibody
Cayman Chemical
Creative Biolabs
Promab Biotechnologies
Leinco Technologies
R&D Systems
Rapid Novor
ACROBiosystems

Related Reports

Global Recombinant Antibody Production Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Recombinant Antibody Production Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 26 Jul 2023

date Service & Software

According to our (Global Info Research) latest study, the global Recombinant Antibody Production Service market size was valued at USD 837.6 million in 2022 and is forecast to a readjusted size of USD 1207.1 million by 2029 with a CAGR of 5.4% during review period.

Global Recombinant Antibody Production Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Recombinant Antibody Production Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 14 Jan 2024

date Service & Software

According to our (Global Info Research) latest study, the global Recombinant Antibody Production Service market size was valued at USD 837.6 million in 2023 and is forecast to a readjusted size of USD 1207.1 million by 2030 with a CAGR of 5.4% during review period.

Global Recombinant Antibody Production Service Supply, Demand and Key Producers, 2024-2030

Global Recombinant Antibody Production Service Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Service & Software

The global Recombinant Antibody Production Service market size is expected to reach $ 1207.1 million by 2030, rising at a market growth of 5.4% CAGR during the forecast period (2024-2030).

Product Tags

Recombinant Antibody Production Service

Custom Recombinant Antibody Production Service

High-Throughput Recombinant Antibody Production Service

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>